Navigation Links
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
Date:11/11/2013

forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Email: tfromer@kcsa.com / grussell@kcsa.com

Media Contacts:
Lewis Goldberg / Samantha Wolf
KCSA Strategic Communications
Phone: 212-896-1216 / 212-896-1220
Email: lgoldberg@kcsa.com / swolf@kcsa.com

 CONSOLIDATED STATEMENTS OF OPERATIONS (1)(U.S. dollars in thousands, except per share data)Three months endedSeptember 30,20132012Revenues$1,552$509Cost of Revenues

750230Gross Profit802279Operating Expenses:Research and development expenses

1,544946Selling and marketing

830402General and administrative

2,3132,212Total operating expenses

4,6873,560Loss from Operations

(3,885)(3,281)Financial expenses

574,218Loss before income taxes

(3,942)(7,499)Tax expenses

37Net Loss($3,945)($7,506)Net loss per share – basic and diluted

($0.12)($0.44)Weighted average number of shares of common stock used in
computing net loss per share – basic and diluted

33,959,77317,074,235 RECONCILIATION OF NON-GAAP NET LOSS (2)(U.S. dollars in thousands, except per share data)Three months endedSeptember 30,20132012GAAP Net Loss($3,945)($7,506)Non-GAAP Adjustments:Non
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22 2015 /CNW/ - The Taskforce representing Canada,s ... all the hard work that the Minister and Health Canada ... This program recognizes the needs of the thalidomide survivors, and ... a year, tax free, with annual adjustments for inflation. ... annual payments of $100,000 based on the severity of their ...
(Date:5/22/2015)... -- BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading developer, ... and cryopreservation freeze media and precision ... the "Company"), announced that the Company is scheduled to present ... Company is scheduled to present at the Conference at 1:30 ... Hyatt Hotel in New York City ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015  RegeneRx ... focused on tissue protection, repair and regeneration, today announced ... RegeneRx, is scheduled to present a corporate overview at ... will present at the SeeThruEquity 4 th Annual ... New York City at 11:00 am ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... 2011 Masimo (NASDAQ: ... of Health & Human Services (HHS) has added Critical ... as a national newborn screening standard.  In addition, the ... detection, published online in the Lancet (appearing ...
... Janssen Biotech, Inc. announced today that the U.S. ... for the treatment of moderately to severely active ulcerative ... inadequate response to conventional therapy.  This marks the 16th ... for the anti-tumor necrosis factor (TNF)-alpha in the treatment ...
Cached Medicine Technology:U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 2U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 3U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 4U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 5U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 6U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 7U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 8U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 9U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 10REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 2REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 3REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 4REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 5REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 6REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 7REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 8
(Date:5/24/2015)... (PRWEB) May 24, 2015 EnviroLeather™ ... launches “InkGard™ Plus” – a classic, rugged leather ... polymer allowing difficult stains, including ink, to be ... different colors suitable for corporate, healthcare, hospitality and ... line with EnviroLeather’s goal of developing products that ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... May 23, 2015 With the implementation ... are finding it increasingly difficult to provide their employees ... to provide adequate insurance for employees stand to face ... such an integral part of a business’s success or ... for businesses, Online USA Doctors has created a varying ...
(Date:5/23/2015)... Janesville, WI (PRWEB) May 23, 2015 ... Mercy Acceleration at the Sports Medicine and Rehabilitation Center, ... running clinic program, Mondays, June 1-July 20, 5:30-6:30 pm. ... MS, USAT coach, and Laurie Finke, RN, BSN, who ... flexibility exercises, education on nutrition, running mechanics and show ...
(Date:5/22/2015)... Francisco, CA (PRWEB) May 22, 2015 ... hosting two exciting events in June. They will hold ... Professional Doctorate and a two-day class on Classical Chinese ... p.m. June 3, Dr. Steve Given, the Dean of ... will discuss the new First Professional Doctorate program. ACTCM ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2
... TORONTO, Feb. 12 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... the company,s,business direction in light of the recent decision ... to the FDA, PreMD today filed a request ... accordance with the following Code of Federal Regulations 21,CFR ...
... Asoyia-MO is the first and only soybean oil to provide ... fats per serving, and light, clean taste., IOWA CITY, ... a new product that not only meets the increasing,consumer demand ... of stability and neutral taste so important to food processors., ...
... individuals or families may have underlying speech deficits ... a personal or family history of learning disabilities may ... dementia that causes them to lose language abilities as ... The condition, known as primary progressive aphasia, causes language ...
... Comprehensive Account of Global Trends, Progress and ... with Response Planning, ANNAPOLIS, Md., Feb. 12 ... global intelligence and business resiliency services,today announced the ... and,Pandemic Planning. Created by iJET,s health intelligence team, ...
... and American Heart Association Join Forces to,Educate, ... Health, CHICAGO, Feb. 12 A recent ... Heart,Association found that, among African-Americans, two out of ... and two out of,five (40 percent) expressed concern ...
... Hutchinson - Named President and CEO of Prematics(TM) - ... Advancing Physician Adoption of Electronic Prescribing, BETHESDA, ... named Kevin Hutchinson, one of the nation,s most respected ... chief,executive officer of SureScripts, to lead the company,s next ...
Cached Medicine News:Health News:PreMD Initiates FDA Review Process and Provides Corporate Update 2Health News:PreMD Initiates FDA Review Process and Provides Corporate Update 3Health News:Asoyia Announces New Mid Oleic Ultra Low Lin Soybean Oil 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning 2Health News:iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning 3Health News:New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 2Health News:New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 3Health News:New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 4Health News:Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices 2Health News:Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices 3
... Profile Ergonomic Design for Neurosurgery. ... offers rigid working channel scopes ... The rigid scope body facilitates ... the target. The steerable tip ...
... Ethisorb Dura Patch is a synthetic absorbable ... and. spinalis defects. Ethisorb Dura Patch is pliable, ... cut to the desired shape, care must be ... violet dyed, PDS foil covered side is oriented ...
... patch, Duragen is a matrix for ... handles and conforms similar to normal ... matrix for dural closure. Remarkable onlay ... defects. Fully resorbed following complete tissue ...
Elmed electrosurgical systems for major surgery....
Medicine Products: